Back to Search
MARC MICHAELSON, MD PHD
MD PHD
Medical Oncology Physician
NPI: 1275523490IndividualAccepts Medicare
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
159790(MA)
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
159790(MA)
Education
ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY
Class of 1997
Research & Publications (20)
Case records of the Massachusetts General Hospital. Case 17-2008. A 63-year-old man with metastatic renal-cell carcinoma.
PMID 18509125·N Engl J Med·2008
5-case
ASCO 2006 highlights: targeted therapy for renal cell carcinoma.
PMID 17367939·Cancer Treat Rev·2007
8-other
Randomized controlled trial of annual zoledronic acid to prevent gonadotropin-releasing hormone agonist-induced bone loss in men with prostate cancer.
PMID 17369566·J Clin Oncol·2007
4-observational
Randomized phase II study of atrasentan alone or in combination with zoledronic acid in men with metastatic prostate cancer.
PMID 16804927·Cancer·2006
3-trial
Bisphosphonates for treatment and prevention of bone metastases.
PMID 16278476·J Clin Oncol·2005
6-review
Selective bladder preservation for muscle-invasive transitional cell carcinoma of the urinary bladder.
PMID 14760367·Br J Cancer·2004
6-review
Contribution of androgen deprivation therapy to elevated osteoclast activity in men with metastatic prostate cancer.
PMID 15102674·Clin Cancer Res·2004
8-other
A Phase I study of 9-nitrocamptothecin given concurrently with capecitabine in patients with refractory, metastatic solid tumors.
PMID 12491516·Cancer·2003
3-trial
The role of bisphosphonates in the management of metastatic prostate cancer.
PMID 12667423·Curr Oncol Rep·2003
6-review
Transitional cell carcinoma of the upper uroepithelial tract.
PMID 16224387·Clin Adv Hematol Oncol·2003
5-case
NCCN clinical practice guidelines in oncology: kidney cancer.
PMID 19555584·J Natl Compr Canc Netw·2009
6-review
A comparison of two mechanisms of severe paediatric injury in northern Israel.
PMID 19328486·Injury·2009
4-observational
Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma.
PMID 19487381·J Clin Oncol·2009
3-trial
NCCN clinical practice guidelines in oncology: testicular cancer.
PMID 19555582·J Natl Compr Canc Netw·2009
6-review
New treatments for renal cell carcinoma: targeted therapies.
PMID 19555586·J Natl Compr Canc Netw·2009
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 55 FRUIT ST, COX 640 HEMATOLOGY ONCOLOGY
BOSTON, MA 02114 - Phone
- (617) 726-5187
Quick Facts
- NPI
- 1275523490
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 29
- Publications
- 20
Are you this provider?
Claim Your Profile